[Form 4] Keurig Dr Pepper Inc. Insider Trading Activity

Rhea-AI Filing Summary

Olivier Lemire, President, U.S. Coffee at Keurig Dr Pepper (KDP), was granted 3,784 restricted stock units (RSUs) on September 17, 2025. Each RSU represents a contingent right to one share of KDP common stock upon vesting. The RSUs are subject to time-based vesting in four equal installments: 25% on September 17 of 2026, 2027, 2028 and 2029. Following the grant, Lemire beneficially owns 3,784 shares represented by these RSUs on a direct basis. The Form 4 was signed by Mark Jackson as attorney-in-fact on September 19, 2025, and indicates the reporting person is both an officer and a director of the issuer.

Insights

Compensation & Governance Analyst

TL;DR: Routine, time‑based equity grant to an executive to align incentives; size appears modest.

The grant of 3,784 RSUs to Olivier Lemire is a standard long‑term incentive aimed at retention and alignment with shareholder interests. The four‑year, annual 25% vesting schedule is typical for executive equity awards and creates service‑based vesting rather than immediate dilution. The disclosure is clear on grant size, vesting dates, and that each RSU converts to one common share upon vesting. The filing was executed by an attorney‑in‑fact, indicating administrative handling. There is no additional information on grant valuation, tax withholding provisions, or whether the award is part of a broader annual award program.

Securities Compliance Specialist

TL;DR: Form 4 appears complete for this transaction and follows Section 16 reporting conventions.

The Form 4 reports a non‑derivative acquisition of RSUs with transaction date 09/17/2025 and reports beneficial ownership of 3,784 RSUs on a direct basis. The explanation clarifies the vesting schedule and one‑for‑one conversion to common stock. The filing includes the reporter's role and the signature by an authorized attorney‑in‑fact dated 09/19/2025. There are no amendments, exercises, dispositions, or derivative instruments disclosed. From a compliance standpoint, the report contains the essential elements required under Section 16 for this type of award.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lemire Olivier

(Last) (First) (Middle)

53 SOUTH AVENUE

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Keurig Dr Pepper Inc. [ KDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, U.S. Coffee

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	09/17/2025		A		3,784		(1)	(1)	Common Stock	3,784	$0	3,784	D

Explanation of Responses:

1. Subject to certain vesting conditions and exceptions, these RSUs vest in four equal installments as follows: 25% on September 17, 2026; 25% on September 17, 2027; 25% on September 17, 2028, and 25% on September 17, 2029. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Remarks:

	/s/ Mark Jackson, attorney in fact	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Olivier Lemire report on the KDP Form 4?

The Form 4 reports a grant of 3,784 restricted stock units (RSUs) to Olivier Lemire dated 09/17/2025.

What is the vesting schedule for the RSUs granted to the KDP executive?

The RSUs vest in four equal installments: 25% on September 17, 2026; 25% on September 17, 2027; 25% on September 17, 2028; and 25% on September 17, 2029.

How many shares will each RSU convert into for KDP?

Each RSU represents a contingent right to receive one share of KDP common stock upon vesting.

What is the reporting person’s role at Keurig Dr Pepper (KDP)?

The filer is listed as President, U.S. Coffee and is reported as an officer and director of KDP.

When was the Form 4 signed and by whom?

The Form 4 was signed on 09/19/2025 by Mark Jackson, attorney‑in‑fact for the reporting person.